| Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland M Meriluoto, L Hedman, L Tanner, V Simell, M Mäkinen, S Simell, ... Emerging infectious diseases 18 (2), 264, 2012 | 130 | 2012 |
| A homozygous FANCM mutation underlies a familial case of non-syndromic primary ovarian insufficiency B Fouquet, P Pawlikowska, S Caburet, C Guigon, M Mäkinen, L Tanner, ... Elife 6, e30490, 2017 | 73 | 2017 |
| Nutrient intake in lysinuric protein intolerance LM Tanner, K Näntö‐Salonen, J Venetoklis, S Kotilainen, H Niinikoski, ... Journal of Inherited Metabolic Disease: Official Journal of the Society for …, 2007 | 57 | 2007 |
| Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues V Biancalana, S Scheidecker, M Miguet, A Laquerrière, NB Romero, ... Acta neuropathologica 134, 889-904, 2017 | 55 | 2017 |
| B-cell responses to human bocaviruses 1–4: new insights from a childhood follow-up study K Kantola, L Hedman, L Tanner, V Simell, M Mäkinen, J Partanen, ... PLoS One 10 (9), e0139096, 2015 | 55 | 2015 |
| Nephropathy advancing to end-stage renal disease: a novel complication of lysinuric protein intolerance LM Tanner, K Näntö-Salonen, H Niinikoski, T Jahnukainen, P Keskinen, ... The Journal of pediatrics 150 (6), 631-634. e1, 2007 | 52 | 2007 |
| Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity HT Siljander, R Hermann, A Hekkala, J Lähde, L Tanner, P Keskinen, ... European journal of endocrinology 169 (4), 479-485, 2013 | 46 | 2013 |
| Long-term oral lysine supplementation in lysinuric protein intolerance LM Tanner, K Näntö-Salonen, H Niinikoski, K Huoponen, O Simell Metabolism 56 (2), 185-189, 2007 | 37 | 2007 |
| Hazards associated with pregnancies and deliveries in lysinuric protein intolerance L Tanner, K Näntö-Salonen, H Niinikoski, R Erkkola, K Huoponen, ... Metabolism 55 (2), 224-231, 2006 | 29 | 2006 |
| Carnitine deficiency and L-carnitine supplementation in lysinuric protein intolerance LM Tanner, K Näntö-Salonen, MS Rashed, S Kotilainen, M Aalto, ... Metabolism 57 (4), 549-554, 2008 | 27 | 2008 |
| Dysfunction in macrophage toll-like receptor signaling caused by an inborn error of cationic amino acid transport J Kurko, M Vähä-Mäkilä, M Tringham, L Tanner, S Paavanen-Huhtala, ... Molecular immunology 67 (2), 416-425, 2015 | 26 | 2015 |
| Combined hyperlipidemia in patients with lysinuric protein intolerance LM Tanner, H Niinikoski, K Näntö‐Salonen, O Simell Journal of Inherited Metabolic Disease: Official Journal of the Society for …, 2010 | 21 | 2010 |
| Urine beta2-microglobulin is an early marker of renal involvement in LPI M Kärki, K Näntö-Salonen, H Niinikoski, LM Tanner JIMD Reports, Volume 25, 47-55, 2016 | 19 | 2016 |
| Diagnostic methods for and clinical pictures of polyomavirus primary infections in children, Finland T Chen, L Tanner, V Simell, L Hedman, M Mäkinen, M Sadeghi, R Veijola, ... Emerging infectious diseases 20 (4), 689, 2014 | 18 | 2014 |
| Exploring the transcriptomic variation caused by the Finnish founder mutation of lysinuric protein intolerance (LPI) M Tringham, J Kurko, L Tanner, J Tuikkala, OS Nevalainen, H Niinikoski, ... Molecular genetics and metabolism 105 (3), 408-415, 2012 | 18 | 2012 |
| Growth hormone therapy is safe and effective in patients with lysinuric protein intolerance H Niinikoski, R Lapatto, M Nuutinen, L Tanner, O Simell, K Näntö-Salonen JIMD Reports-Case and Research Reports, 2011/1: Case and Research Reports, 43-47, 2011 | 16 | 2011 |
| Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI) J Kurko, M Tringham, L Tanner, K Näntö-Salonen, M Vähä-Mäkilä, ... Metabolism 65 (9), 1361-1375, 2016 | 15 | 2016 |
| Inhaled sargramostim induces resolution of pulmonary alveolar proteinosis in lysinuric protein intolerance LM Tanner, J Kurko, M Tringham, H Aho, J Mykkänen, K Näntö-Salonen, ... JIMD Reports, Volume 34, 97-104, 2017 | 14 | 2017 |
| Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment HH Pitkänen, M Kärki, H Niinikoski, L Tanner, K Näntö‐Salonen, M Pikta, ... Haemophilia 24 (5), e312-e321, 2018 | 13 | 2018 |
| A long-term follow-up study on disclosing genetic risk information (APOE) to promote healthy lifestyles in Finland HL Hietaranta-Luoma, M Tringham, H Karjalainen, L Tanner, ... Lifestyle Genomics 11 (3-6), 147-154, 2019 | 8 | 2019 |
